Oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients by developing and commercializing safer and more effective therapeutics
- Year invested 2010
- Investment Stage Early
- Sectors
- Investment Status Historic
- Associated Team
- Website tesarobio.com
- Company Status IPO/Acquired (by GlaxoSmithKline) (Nasdaq: TSRO)